Orphans Dominate Products Seeking End-Of-Year Joy From CHMP

Five of the nine products that could this week be recommended for EU approval have orphan designation. The final meeting this year of the European Medicines Agency’s key scientific committee, the CHMP, is under way in London.

Hurdles
Pan-EU approval is all but guaranteed for products clearing the CHMP hurdle • Source: Shutterstock

New therapies for conditions ranging from diabetes and adrenal insufficiency to ovarian cancer and multiple myeloma and a biosimilar version of Roche’s Herceptin could this week receive a recommendation for marketing across the EU.

At its final meeting of the year, the European Medicines Agency’s key scientific committee, the CHMP, is – among many...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Product Reviews

More from Pink Sheet